Описание: The third in the series, this Just Between Us webinar will feature 374 Labs. This candid interview will explore the decision process for expanding laboratory capabilities when growth exceeds expectations. The considerations for meeting current-day customer expectations while anticipating growth capabilities can be difficult. The ability to research products to help with productivity while balancing economic considerations and speed to implementation is a critical part of the decision to laboratory readiness.
Founded in 2014, 374 Labs is one of the first cannabis testing labs in to be awarded a testing license in the state of Nevada and is also the first Nevada-based cannabis testing lab to achieve ISO/IEC 17025:2005 certification. Their customers comprise hundreds of cannabis/hemp/CBD producers, farmers, and cultivators of all sizes not only around the country, but also around the world. Over the years, 374 Labs has developed a high degree of expertise in helping their customers understand and resolve their challenges, especially with complex issues such as nutrient blend issues or pesticide problems.
Key Learning Objectives:
- Where to acquire resources for product considerations
- How to evaluate the cost per analysis versus capital investment
- Balancing time
Лектори: Jason Strull, Lab Supervisor, 374 Labs
Saied Habibzadeh, Lab Manager, 374 Labs
Angela Tsao, Account Manager for Elemental Analysis, Agilent Technologies, Inc.
Kenneth Fredeen, PhD, Product Manager, Milestone Inc.
Продължителност: 54 минути
Дата: 15 декември 2021, 20:00 ч. българско време